Methodological considerations for interpreting ketamine-naltrexone trials in depression.
Saved in:
| Title: | Methodological considerations for interpreting ketamine-naltrexone trials in depression. |
|---|---|
| Authors: | Bandeira ID; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Jelen LA; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; South London and Maudsley NHS Foundation Trust, London, United Kingdom., Tucciarone JM; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Heifets BD; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States., Rodriguez CI; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States., Schatzberg AF; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States. |
| Source: | The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2025 Oct 01; Vol. 28 (10). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1469-5111 |
|---|---|
| DOI: | 10.1093/ijnp/pyaf073 |
